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Abstract Genomic islands are foreign DNA blocks
inserted in so-called regions of genomic plasticity
(RGP). Depending on their gene content, they are
classified as pathogenicity, symbiosis, metabolic,
fitness or resistance islands, although a detailed
functional analysis is often lacking. Here we focused
on a 34-kb pathogenicity island of Pseudomonas
aeruginosa PA14 (PA14GI-6), which is inserted at
RGP5 and carries genes related to those for pyochelin/
enantiopyochelin biosynthesis. These enantiomeric
siderophores of P. aeruginosa and certain strains of
Pseudomonas protegens are assembled by a thiotem-
plate mechanism from salicylate and two molecules of
cysteine. The biochemical function of several proteins
encoded by PA14GI-6 was investigated by a series of
complementation analyses using mutants affected in
potential homologs. We found that PA14_54940 codes
for a bifunctional salicylate synthase/salicyl-AMP
ligase (for generation and activation of salicylate),
that PA14_54930 specifies a dihydroaeruginoic acid
(Dha) synthetase (for coupling salicylate with a
cysteine-derived thiazoline ring), that PA14_54910
produces a type II thioesterase (for quality control),
and that PA14_54880 encodes a serine O-acetyltrans-
ferase (for increased cysteine availability). The struc-
ture of the PA14GI-6-specified metabolite was
determined by mass spectrometry, thin-layer chroma-
tography, and HPLC as (R)-Dha, an iron chelator with
antibacterial, antifungal and antitumor activity. The
conservation of this genomic island in many clinical
and environmental P. aeruginosa isolates of different
geographical origin suggests that the ability for Dha
production may confer a selective advantage to its
host.
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Introduction
The Gram-negative bacterium Pseudomonas aerugin-
osa is found ubiquitously in soil and aquatic environ-
ments and is virulent towards a large variety of
organisms including plants, nematodes, amoeba,
insects, and mammals (D’Argenio et al. 2001; Galla-
gher and Manoil 2001; Plotnikova et al. 2000;
Pukatzki et al. 2002). Over the past century, it has
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emerged as an important opportunistic human patho-
gen causing several nosocomial infections (Van
Delden and Iglewski 1998). More notably, P. aeru-
ginosa is recognised as the main cause for chronic lung
infection in patients suffering from the genetic disease
cystic fibrosis (Lyczak et al. 2002). The ability of P.
aeruginosa to cause a wide range of acute and chronic
infections is based not only on its large arsenal of
secreted virulence factors and secondary metabolites
but also on its metabolic versatility and high potential
for adaptation. Not surprisingly therefore, the P.
aeruginosa genome is larger than those of most
sequenced bacteria and varies between 5.5 and 7 Mbp
(Schmidt et al. 1996; Lee et al. 2006). The difference
in genome size between strains results from the so-
called accessory genome which consists of extrachro-
mosomal elements (e.g. plasmids) and of chromo-
somal insertions of foreign DNA blocks acquired by
horizontal gene transfer. These insertions tend to
cluster at certain loci which have been termed
‘‘regions of genomic plasticity’’ (RGP; Mathee et al.
2008). The presence of these chromosomal inserts
may confer a selective advantage to the strain and,
according to their gene content, these inserts are
tentatively assigned as pathogenicity, symbiosis,
metabolic, fitness, or resistance islands (Juhas et al.
2008). In many cases however, a functional analysis of
the relevant genes has not yet been carried out.
Here we focus on a DNA block inserted at RGP5 in
the highly virulent strain PA14 (Mathee et al. 2008).
This block, which carries 23 genes (PA14_54850 to
PA14_55090), was originally termed genomic island 6
(PA14GI-6; Song and Zhang 2009) but later described
as PA14GI-3 (Song and Zhang 2011); we will use the
original designation PA14GI-6 here. Sequence ana-
lysis predicted that PA14GI-6 qualified as a pathoge-
nicity island as it carries genes for the biosynthesis of a
putative siderophore, for TonB-dependent receptors
and ABC transport systems (Song and Zhang 2009).
Indeed, some of the PA14GI-6 genes closely ressemble
those specifying pyochelin (Pch) and enantiopyochelin
(EPch) (Fig. 1), two enantiomeric siderophores pro-
duced by P. aeruginosa and P. protegens, respectively
(Youard et al. 2011). Biosynthesis of Pch and EPch
proceeds via a thiotemplate mechanism in which
salicylate is coupled to two molecules of cysteine
which are cyclized and modified during the assembly
(Fig. 2; reviewed by Youard et al. 2011). Here we
investigate the function of the Pch/EPch-related sider-
ophore biosynthesis genes of PA14GI-6 and we
determine the structure of the molecule they specify.
Materials and methods
Bacterial strains, plasmids and culture conditions
Table 1 lists the strains and plasmids used in this
study. Bacteria were routinely cultivated at 37 C
(Escherichia coli and Pseudomonas aeruginosa) and
30 C (Pseudomonas protegens) on nutrient agar and
in nutrient yeast broth (Stanisich and Holloway
Fig. 1 Pch and EPch
biosynthesis genes of P.
aeruginosa and P.
protegens, respectively, and
their potential counterparts
in genomic island PA14GI-
6. Genes with significant
homology are colored
identically
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1972). To facilite uptake of heterologous DNA
during conjugation and transformation, P. aeruginosa
and P. protegens strains were grown at 43 and 35 C,
respectively. For metabolite extraction, bacteria were
grown in GGP medium (Carmi et al. 1994) in which
iron is present but not immediately accessible, thus
inducing the expression of siderophore biosynthesis
genes. Production of siderophores was assessed on
solid Chrome Azurol S (CAS) agar (Schwyn and
Neilands 1987), which turns orange in the presence
of iron-chelating molecules. Amino acid comple-
mentation experiments with E. coli strain MG1655-C
were carried out on solid M9 medium with 0.5 %
glycerol as a carbon source (Sambrook and Russell
2001). When needed, antibiotics were added to the
media as follows. For E. coli ampicillin (Ap) was
used at 100 lg ml-1 while kanamycin (Km) and
tetracycline (Tc) were used at 25 lg ml-1. For
selection of Ap-resistant plasmids in P. aeruginosa,
carbenicillin (Cb) was used at 250 lg ml-1. Tc was
used at 125 lg ml-1 for both P. aeruginosa and P.
protegens. Counterselection of E. coli donor cells
during mutant construction occurred with chloram-
phenicol (Cm) at 10 lg ml-1; mutant enrichment
was performed with tetracycline at 20 lg ml-1 and
carbenicillin at 2 mg ml-1 (for P. aeruginosa) or
cycloserine at 50 mg ml-1 (for P. protegens). To
activate transcription from tac promoters, isopropyl
b-D-1-thiogalactopyranoside (IPTG) was added at
1 mM final concentration.
Fig. 2 Biosynthesis of Pch and EPch in P. aeruginosa and P.
protegens, respectively. Both siderophores are produced by a
thiotemplate mechanism from salicylate and two cysteine
molecules, which are cyclized during the assembly and undergo
a certain number of modifications (reviewed in Youard et al.
2011). For Pch, these are (1) epimerization of the first cysteine
by PchE, (2) reduction of the second thiazoline ring by PchG and
(3) subsequent N-methylation by PchF. EPch assembly is
essentially identical except that it is the second cysteine which is
epimerized by a so far uncharacterized mechanism and that
reduction appears to be carried out by PchK which has no
sequence homology with PchG. Note that premature hydrolysis
of the thioester bond of the PchE-attached compound can
generate the byproduct Dha (Serino et al. 1997; Patel et al. 2003;
Quadri et al. 1999)
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Table 1 Bacterial strains and plasmids
Name Relevant characteristics Reference/Source
E. coli strains
DH5a recA1 endA1 hsdR17 deoR thi-1 supE44
gyrA96 relA1 D(lacZYA-argF) U169 (/
80dlacZDM15)
Sambrook and Russell (2001)
MG1655 Wild type Bachmann (1987)
MG1655-C DcysE Sturgill et al. (2004)
P. aeruginosa strains
PALS128 pvdB Visca et al. (1992)
PAO6334 pvdB, pchG::XSp/Sm This study
PAO6342 pvdB, DpchC Reimmann et al. (2004)
PAO6382 DpvdF Hoegy et al. (2009)
PAO6383 DpvdF, DpchBA Michel et al. (2007)
PAO6398 DpvdF, pchD::XSp/Sm This study
PAO6399 DpvdF, DpchE Youard et al. (2007)
PAO6402 DpvdF, pchR::x Youard and Reimmann (2010)
PA14 Wild type Lee et al. (2006)
PA14-98 PA14 DpvdF This study
PA14-99 PA14 DpvdF DpchDCBA DpchR
DpchEFGHI
This study
PA14-106 PA14-99 with PA14_54940 to
PA14_54910 under Ptac control
This study
PA14-109 PA14-99 with PA14_54940 to
PA14_54910 under Ptac control and
PA14_54900 to PA14_54880 under
lacIQ-Ptac control
This study
A30 Environmental isolate Pa4, Algeria N. Benzidane
A31 Environmental isolate Pa5, Algeria N. Benzidane
A34 Environmental isolate Pa20, Algeria N. Benzidane
A35 Environmental isolate Pa22, Algeria N. Benzidane
A44 Clinical isolate H3471, University
hospital Lausanne, Switzerland
(CHUV)
D. Blanc
A47 Clinical isolate H7, CHUV D. Blanc
A90 Clinical isolate 7B5, University hospital
Geneva, Switzerland (HUG)
C. Van Delden
A93 Clinical isolate 36D5, HUG C. Van Delden
A97 Environmental isolate 10289, CHUV D. Blanc
A107 Environmental isolate 12049, CHUV D. Blanc
A112 Environmental isolate 13072, CHUV D. Blanc
A116 Environmental isolate 7800, CHUV D. Blanc
A117 Environmental isolate 7852, CHUV D. Blanc
A118 Environmental isolate 7854, CHUV D. Blanc
A120 Environmental isolate 7868, CHUV D. Blanc
A122 Environmental isolate 8093, CHUV D. Blanc
A123 Environmental isolate 8510, CHUV D. Blanc
A124 Environmental isolate 8727, CHUV D. Blanc
A134 Clinical isolate 822, CHUV D. Blanc
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Table 1 continued
Name Relevant characteristics Reference/Source
A135 Clinical isolate 1161, CHUV D. Blanc
A137 Clinical isolate 2114, CHUV D. Blanc
P. protegens strains
CHA1222 DpchR, pvd ::Tn1733, Kmr Youard and Reimmann (2010)
CHA1238 DpvdF Reimmann (2012)
CHA1262 DpvdF, DpchK This work
CHA1264 DpvdF, DpchE This work
Plasmids
pET21a-cysE pET21a derivative carrying cysE of
E. coli, Apr
Sturgill et al. (2004)
pME497 Mobilizing plasmid, Apr Voisard et al. (1994)
pME3087 Suicide vector, ColE1 replicon, Tcr Voisard et al. (1988)
pME6000 pBBR1-based cloning vector, Tcr Maurhofer et al. (1998)
pME6032 lacIQ-Ptac expression vector, Tc
r Heeb et al. (2002)
pME6123 Identical with pME3087-pchD::XSp/Sm,
Tcr, Sp/Smr
Serino et al. (1997)
pME6176 Suicide plasmid to delete pchDCBA,
pchR, and pchEFGHI in P. aeruginosa,
Tcr
Reimmann et al. (2001)
pME6180 Suicide plasmid to generate pchG::XSp/
Sp in P. aeruginosa,Tcr
Reimmann et al. (2001)
pME7152 Suicide plasmid to delete pvdF in P.
aeruginosa,Tcr
Michel et al. (2007)
pME9244 Suicide plasmid to delete pchK in P.
protegens,Tcr
This study
pME9751 Suicide plasmid to delete pchE in P.
protegens,Tcr
This study
pME10075 pME6032 with PA14_54870 under Ptac
control, Tcr
This study
pME10201 pME6000 with PA14_54930 under Plac
control, Tcr
This study
pME10202 pUCPSK with PA14_54940 under Plac
control, Apr
This study
pME10205 pME6000 with PA14_54900 under Plac
control, Tcr
This study
pME10208 pME3087 carrying a 1.2 kb BamHI-
HindIII fragment containing the 30 part
of PA14_54950 and the 50 part of
PA14_54940 under Ptac control, Tc
r
This study
pME10209 pME6032 with PA14_54880 to
PA14_54900 under Ptac control, Tc
r
This study
pME10219 pME3087 carrying a 2.8 kb EcoRI-XbaI
fragment containing the 30 part of
PA14_54910, lacIQ- Ptac, and the 5
0 part
of PA14_54900, Tcr
This study
pME10225 pUCPSK with PA14_54910 under Plac
control, Apr
This study
pUCPSK ColE1-pRO1600 shuttle vector, Apr Watson et al. (1996)
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DNA manipulations and sequencing
DNA manipulations were carried out according to
standard procedures (Sambrook and Russell 2001).
Preparations of plasmid DNA were made using Jetstar
(Genomed GmbH) and QIAprep Spin Miniprep
(Qiagen, Inc.) kits. Chromosomal DNA of P. aeru-
ginosa and P. protegens was purified as described by
Gamper et al. (1992). DNA fragments were extracted
from gels and purified with the Invisorb fragment
cleanUp kit from Invitek. For Southern blotting,
chromosomal DNA of P. aeruginosa strains was
digested overnight with BamHI, separated on a 0.8 %
agarose gel, and transferred to a Hybond-N nylon
membrane (Amersham Biosciences). DNA probe
labeling, hybridization, and detection were done with
the DIG DNA labeling and detection kit (Roche)
according to the manufacturer’s procedures. A DNA
probe covering the entire genomic island was prepared
from 7 PCR fragments generated from chromosomal
DNA of PA14 using the primer pairs GI-1/GI-2bis, GI-
5/GI-6, GI-7/GI-8, GI-9bis/GI-10bis, GI-13/GI-14,
GI-17bis/GI-18bis, and GI-21bis/GI-22bis (Table
S1). Transformations of bacterial strains were done
by electroporation (Farinha and Kropinski 1990).
Constructs based on PCR techniques (for oligonucle-
otides see Table S1) were sequenced commercially by
GATC Biotech.
Construction of mutants and overexpression
strains
Gene replacement mutants of P. aeruginosa and P.
protegens (Table 1) were generated as described
(Schnider et al. 1995; Ye et al. 1995; Laville et al.
1998). The suicide plasmids carrying the relevant
mutations were constructed as follows. First, two PCR
fragments were amplified using the template DNA and
primer pairs listed in Table S2. Then, the two
fragments were combined by overlap extension
PCR, and cloned into pME3087, using the restriction
sites introduced by the two flanking PCR primers (see
Tables S1 and S2). For construction of the suicide
plasmid pME10219, which was used to place the
PA14_54900 to PA14_54880 operon under lacIQ-Ptac
control, overlap extension PCR was used to combine
three PCR fragments as detailed in Tables S1 and S2.
The resulting suicide plasmids were mobilized
from E. coli DH5a to the P. aeruginosa and P.
protegens recipient strains using the helper plasmid
pME497 and subsequently integrated into the chro-
mosome with selection for tetracycline resistance.
Excision of the vector via a second crossing-over was
obtained by enrichment for tetracycline-sensitive
cells. Mutants were identified by PCR and sequence
analysis. Supplementary Table S2 lists the primer
pairs used for generating the suicide plasmids, the P.
aeruginosa and P. protegens recipient strains used for
mutant construction, and the designation of the
mutants generated in this way.
PCR screening to identify potential GI-6 carriers
Pseudomonas aeruginosa isolates were screened for
the presence of GI-6 using the degenerate primers
DpchE1 and DpchE5 (Table S1) which were designed
based on sequence comparison of pchE from P.
aeruginosa, P. protegens, Burkholderia cenocepacia,
Burkholderia pseudomallei and Burkholderia thai-
landensis. The primers specify the amino acid
sequences HWRSIPY and NGKV/I/LDR which flank
the epimerase domain of PchE from P. aeruginosa
strain PAO1. PCR amplification was performed with
GoTaq polymerase (Promega) and whole cell tem-
plates in the presence of 5 % DMSO. After initial
template denaturation at 95 C for 2 min, 5 cycles of
amplification were performed with denaturation at
95 C for 1 min, annealing at 65 C for 1 min, and
elongation at 72 C for 2 min. Then, another 25 cycles
were carried out during which the annealing temper-
ature was lowered to 58 C. A final extension was
done during 3 min. These conditions amplified a
fragment of 1,409 bp, characteristic for a pchE gene
encoding an epimerase domain (such as pchE of P.
aeruginosa PAO1), and a fragment of 524 bp corre-
sponding to a pchE homolog devoid of sequences
specifying an epimerase domain (such as PA14_54930
or pchE of P. protegens).
Construction of expression plasmids
To analyse the function of PA14GI-6-encoded genes
in complementation experiments a series of expres-
sion plasmids were constructed. For constitutive
expression of PA14_54940 (plasmid pME10202) and
PA14_54910 (plasmid pME10225) from Plac, PCR
fragments of 3 kb (amplified from chromosomal DNA
of PA14 using primers 54940fw and 54940bw2) and
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0.9 kb (primer pair AM-36/AM-37) were cloned via
BamHI/SacI and BamHI/XhoI, respectively, into
pUCPSK. For constitutive expression of
PA14_54930 (plasmid pME10201) and PA14_54900
(plasmid pME10205), PCR fragments of 3.5 kb
(obtained from PA14 with primer pair AM-1/AM-2)
and 1.1 kb (primer pair AM-11/AM-12), were cloned
into pME6000 between the restriction sites HindIII/
EcoRI and EcoRI/BamHI, respectively. Inducible
expression of the entire PA14_54900-PA14_54890-
PA14_54880 operon under Ptac control was obtained
with pME10209 as follows. A 3.8-kb PCR fragment
was PCR amplified from PA14 using the primer pair
AM-11 and AM-13, trimmed with EcoRI and BglII
and cloned into pME6032 between the same sites. The
PA14_54870 expression plasmid pME10075 was
constructed in a similar way. The gene was PCR-
amplified from PA14 DNA with the primer pair PA14-
AraC-fw/PA14-AraC-bw, and cloned under Ptac con-
trol into pME6032 using the restriction sites EcoRI
and XhoI of the two primers.
Metabolite extraction and analysis
Pseudomonas aeruginosa strains were grown in GGP
medium for 2 days to stationary phase (OD600 * 7–11).
For HPLC analysis, acidified culture supernatants were
extracted with ethyl acetate, dried under reduced
pressure, then dissolved in 60 % (vol/vol) methanol—
10 mM H3PO4, and injected into HPLC systems as
reported previously (Reimmann et al. 1998; Youard et al.
2007). Compounds were identified based on their
retention times and UV spectra. Preparation of Dha and
Pch standards has been described previously (Serino et al.
1997). Electrospray mass spectrometry experiments were
done on a microTOF LC from Brucker Daltonics.
Analytical Thin-layer chromatography (TLC) was car-
ried out with Merck TLC silica gel 60F254 on aluminum
sheets and n-butyl alcohol/water/acetic acid 4:1:1 (v/v/v)
as the mobile phase. Compounds were detected by
fluorescence at 365 nm or by spraying with a solution of
FeCl3 in MeOH.
Results
Bioinformatic analysis of PA14_54940
to PA14_54870
As illustrated in Fig. 1, the genes of PA14GI-6, which
are potentially involved in the biosynthesis and
regulation of a Pch/EPch-related compound, appear
to be organized in two operons and a separately
transcribed gene. A detailed bioinformatic analysis
(Table 2) showed that the N-terminal part of
PA14_54940 has strong homology with the salicyl-
AMP ligase PchD of P. aeruginosa while its C-termi-
nal part weakly ressembles isochorismate synthase
Table 2 Predicted functions of PA14-GI6 specified proteins based on bioinformatics analyses
Protein of
PA14GI-6
Protein size
(amino acids)
Homologous
proteina
Identical amino
acids (%)
Amino acid
stretch with
homology
Predicted function of the
PA14GI-6 protein
PA14_54940 994 PchD (Pa) 52 9–522 Bifunctional protein with
salicylate synthase and
salicyl-AMP ligase activities
PchA (Pa) 30 693–975
Irp9 (Ye) 41 567–981
PA14_54930 1,113 PchE (Pp) 48 1–1,062 Dha synthetase
PA14_54920 1,487 PchF (Pp) 45 19–933 Desmethyl-enantiopyochelin
synthetasePchF (Pp) 38 955–1,055
PA14_54910 271 PchC (Pp) 43 14–271 Type II thioesterase
PA14_54900 384 PchK (Pp) 31 12–333 Reductase
PA14_54890 634 No homology to
Pch proteins of
Pa and Pp
Motifs indicate saccharopine
dehydrogenase, NAD binding
and ATC hydrolase activities
PA14_54880 292 CysE (Ec) 50 51–287 Serine acetyl transferase
PA14_54870 302 PchR (Pa) 34 143–289 AraC-type regulator
a Note that if homology was detected to proteins of P. aeruginosa (Pa) and P. protegens (Pp), only the protein with stronger
homology is listed
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PchA. Interestingly, a stronger homology of the
C-terminal part was found with Irp9 of Yersinia
enterocolitica, an enzyme which converts chorismate
directly to salicylate. We thus predicted that
PA14_54940 may have salicylate synthase and sali-
cyl-AMP ligase activities.
The stop codon of PA14_54940 overlaps with the
start codon of PA14_54930, which codes for a protein
ressembling the peptide synthetases PchE of P. prote-
gens (PchEPp) (Table 2) and P. aeruginosa (PchEPa)
(not shown). These proteins couple salicylate to the first
L-cysteine moiety. During Pch biosynthesis (Fig. 2), L-
cysteine is converted by a dedicated epimerase domain
of PchEPa to its D-enantiomer. Such a domain is absent
from PchEPp and PA14_54930, suggesting that
PA14_54930 is a Dha synthetase, generating a mole-
cule whose stereochemical configuration at the chiral
center C40 is identical with that of EPch (Fig. 2).
The third gene of this first operon is PA14_54920;
its start codon overlaps with the stop codon of
PA14_54930. PA14_54920 displays homology to the
Pch and EPch synthetases PchF of P. aeruginosa
(PchFPa) and P. protegens (PchFPp), respectively, with
a closer relatedness to the latter (Table 2). However,
unlike the two PchF proteins, PA14_54920 does not
have a dedicated methyltransferase domain required
for adding a methyl group to the thiazoline rings of Pch
and EPch (Fig. 2). Moreover, the C-terminal part of
PA14_54920 has no ressemblance to the thioesterase
domains of PchFPa and PchFPp. Instead, it presents a
typical NAD binding motif, suggesting that product
release may be carried out by a thioester reductase
mechanism (Du and Lou 2010). PA14_54910, last
gene of the PA14_54940 to PA14_54910 operon,
encodes a putative type II thioesterase, which is most
closely related to PchC of P. protegens. Its P.
aeruginosa homolog was shown to be required for
quality control of Pch biosynthesis by removing
wrongly charged substrates from the peptide synthe-
tases PchE and/or PchF (Reimmann et al. 2004).
The second operon potentially implicated in the
biosynthesis of a Pch/EPch-related compound is
comprised of three genes. The first one,
PA14_54900, codes for a protein which is related to
PchK of P. protegens. Although the function of PchK
has not been demonstrated experimentally, the protein
is believed to be a functional homolog of PchG,
carrying out the reduction of the second thiazoline ring
(Fig. 2). In addition to the motifs shared with PchK,
bioinformatics identified a motif which is caracteristic
of proteins carrying out an epimerase reaction, indi-
cating that PA14_54900 could be a bifunctional
protein.
The stop codon of PA14_54900 overlaps with the
start codon of PA14_54890. Its deduced amino acid
sequence does not reveal homology to proteins
implicated in the biosynthesis of Pch and EPch. Based
on its NAD binding motif and a certain resemblance
with saccharopine dehydrogenases, PA14_54890 may
function as an oxidoreductase.
The last gene of the operon, PA14_54880, has no
counterpart in the Pch/EPch gene clusters either.
However, its deduced amino acid sequence revealed
strong homology to CysE of Escherichia coli, an
enzyme which converts serine to O-acetylserine
during cysteine biosynthesis.
The operon PA14_54900 to PA14_54880 is fol-
lowed by the separately transcribed gene PA14_54870,
which codes for an AraC-type regulator ressembling
PchR of P. aeruginosa (PchRPa). This protein, and its
counterpart in P. protegens (PchRPp) bind their cognate
siderophores Pch and EPch, respectively, and upregu-
late the transcription of the Pch/EPch biosynthesis and
transport genes (Lin et al. 2013; Youard et al. 2011).
Taken together, bioinformatics revealed that the
siderophore biosynthesis genes of PA14GI-6 appear to
be more related to the EPch biosynthetic genes than to
those specifying Pch, suggesting that the stereochem-
istry of the molecule specified by PA14GI-6 could be
identical with that of EPch.
Functional analysis of PA14GI-6 genes
In the following, we tested the predicted functions of
several PA14GI-6 genes by complementation analyses
using P. aeruginosa, P. protegens and E. coli mutants
affected in potential homologs. We first evaluated
whether PA14_54940 could restore Pch production in
P. aeruginosa mutants deleted for pchBA (PAO6383)
or carrying an X cassette inserted in pchD (PAO6398),
respectively. Both mutants are pyoverdine (Pvd)
negative due to a deletion in pvdF, allowing the
production of Pch to be evaluated visually by the
formation of an orange halo on CAS agar plates. As
shown in Fig. 3a, constitutive expression of
PA14_54940 from the lac promoter of plasmid
pME10202 fully restored Pch production in
PAO6383 and also led to a minor production of Pch
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in PAO6398. We thus conclude that PA14_54940
encodes a bifunctional enzyme with salicylate syn-
thase and salicyl-AMP ligase activities.
Next, we addressed the function of
PA14_54930, which was expressed under Plac
control in plasmid pME10201. Introduction of this
plasmid restored production of EPch in CHA1264,
a Pvd-negative P. protegens mutant deleted for
pchE (Fig. 3b). By contrast, PA14_54930 was
unable to restore Pch production in the analogous
P. aeruginosa mutant PAO6399 (data not shown).
These data show that PA14_54930 specifies indeed
a dihydroaeruginoic acid synthetase which is
expected to generate the same stereochemical
configuration at the chiral center C40 than does
PchE of P. protegens (Fig. 2).
Fig. 3 Functional analysis
of PA14_54940 (a),
PA14_54930 (b),
PA14_54910 (c) and
PA14_54880 (d) by
complementation analyses.
Formation of orange halos
around bacterial colonies of
Pvd-negative strains grown
on CAS agar plates is
indicative of Pch (a, c) or
EPch (b) production. Serine
acetyl transferase activity
was identified by cysteine-
independent growth of the
indicated E. coli strains on
M9 minimal medium
containing 1 mM IPTG.
Note that growth of the cysE
deletion mutant MG1655-C
occurred only in close
proximity of a filter paper
soaked with DL-cysteine
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The function of PA14_54920 was not tested
because it seemed unlikely that a protein lacking a
dedicated methyltransferase domain would be able to
replace PchF in P. aeruginosa or P. protegens.
Instead, we showed that PA14_54910 is a func-
tional homolog of the type II thioesterase PchC. In
agreement with previous observations (Reimmann
et al. 2004), we found that pyochelin production was
reduced, but not abolished, in the Pvd-negative pchC
mutant PAO6342, compared with production in its
PchC-positive parent strain PALS128 (Fig. 3c). Con-
stitutive expression of PA14_54910 on plasmid
pME10225 partially restored Pch production, con-
firming the predicted role of this PchC homolog in
quality control of siderophore assembly.
We then evaluated wether PA14_54900 would be able
to complement the Pvd-negative pchK mutant CHA1262.
However, no siderophore production by CHA1262 was
observed when PA14_54900 was expressed from the lac
promoter of pME10205 (data not shown).
Fig. 4 Identification of the metabolite specified by PA14GI-6 as
(R)-Dha. a HPLC analysis of culture supernatant extracts from
PA14-98 (trace c), PA14-99 (trace d), PA14-106 (trace e) and
PA14-109 (trace f) compared with standards of Pch (trace a) and
Dha (trace b). Note that due to the spontaneous isomerisation at
the chiral center C200, Pch occurs as a mixture of two isomers.
EPch was not used as a standard here as the retention times of its
two isomers are identical with those of PchI and PchII on the
reversed phase C-18 column used. b Migration of the PA14GI-6-
specified metabolite was compared with a Dha standard by thin
layer chromatography. Lane 1 metabolite; lane 2 co-spot; lane 3
Dha standard. c Chiral HPLC of culture supernatant extract from
PA14-109 (trace c) compared with standards of (R)-Dha (trace a)
and (S)-Dha (trace b). Trace d, metabolite mixed with (R)-Dha;
trace e, metabolite mixed with (S)-Dha
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To demonstrate the activity of the predicted serine
O-acetyltransferase PA14_54880, we tested whether
PA14_54880 would complement a cysE mutation in
the E. coli strain MG1655-C. As shown in Fig. 3d,
cysteine-indepent growth occurred in the correspond-
ing wildtype strain MG1655, but not in MG1655-C.
Growth was restored in this mutant with E. coli cysE
gene (carried by pET21-cysE) and with PA14_54880
(carried by plasmid pME10209) confirming the pre-
dicted function of this gene.
Finally we tested if the AraC-type regulator
PA14_54870 would be able to replace PchR in P.
aeruginosa or P. protegens. However, expression of
this gene under Ptac control did not allow the Pvd-
negative pchR mutants PAO6402 and CHA1222 to
produce Pch and EPch, respectively (data not shown).
Fig. 5 Occurrence of GI-6
in environmental and
clinical P. aeruginosa
isolates. a Genes of GI-6 in
the chromosome of strain
PA14 and size of DNA
fragments generated by in
silico restriction with
BamHI (in bp). b BamHI
fragments of chromosomal
DNA of PA14, PAO1 and of
21 GI-6 carriers were
separated by agarose gel
electrophoresis, transferred
to a nylon membrane and
hybridized against a
PA14GI-6-specific
digoxygenin-labeled DNA
probe
Biometals (2014) 27:559–573 569
123
Clearly, PA14_54870 is not able to function as a
transcriptional activator with Pch or EPch as effectors.
Structural identification of the metabolite specified
by PA14GI-6
Based on bioinformatics and complementation exper-
iments we predicted that the molecule specified by
PA14GI-6 would be essentially composed of two
cysteine-derived rings joined to salicylate. To purify
large amounts of this molecule for structural identi-
fication, we generated the two Pvd and Pch-negative
overexpression strains PA14-106 and PA14-109, in
which genes of the first operon (PA14_54940 to
PA14_54910) or those of both operons (PA14_54940
to PA14_54910 and PA14_54900 to PA14_54880) are
expressed under Ptac control. HPLC analysis (Fig. 4a)
of culture supernatant extracts showed one major
peak, irrespective of whether one (trace e) or both
operons (trace f) had been overexpressed. This peak
was different from those corresponding to Pch/EPch
(traces a [Pch standard] and c [extract of the Pvd-
negative strain PA14-98]) and was not produced with
an extract of the Pvd- and Pch-negative strain PA14-
99 in which the two operons had not been artificially
overexpressed (trace d). Surprisingly, the retention
time of this peak was identical with that of Dha. For
further structural identification of the PA14GI-6-
specified metabolite, the culture supernatant extract
of PA14-109 was washed, purified on a metal-free
silica gel column and subsequently analyzed by
electrospray mass spetrometry. The ionic profile
presented a peak at m/z 224 (M ? H?) corresponding
to the molecular weight of Dha (MW = 223). TLC
analysis confirmed these results in that the PA14GI-6-
specified metabolite co-migrated perfectly with a
synthetic Dha standard (Fig. 4b). Finally, we inves-
tigated the stereochemistry of the compound by chiral
HPLC and found that it had the same retention time as
(R)-Dha, the byproduct of EPch biosynthesis
(Fig. 4c).
Identification of GI-6 in clinical and environmental
P. aeruginosa isolates
To easily detect potential GI-6 carriers among natural
isolates of P. aeruginosa, a PCR-based screening
method was developed which is based on the size
differences of pchE and PA14_54930. This method
produces a 1,409 bp fragment caracteristic for pchEPa,
and an additional fragment of 524 bp characteristic for
a gene resembling PA14_54930. We screened 110
clinical (isolated from patients) and 42 environmental
P. aeruginosa isolates from different geographical
origins and identified a total of 21 potential GI-6
carriers (data not shown). To test whether the entire
genomic island was conserved in these candidates,
chromosomal DNA was isolated, cleaved with BamHI
and hybridized against a PA14GI-6- specific probe. As
illustrated in Fig. 5, Southern analysis revealed that
most isolates had a banding pattern which was
identical to that of PA14. In some cases, the pattern
was slightly modified, probably because not all
BamHI sites are conserved. Although we cannot
exclude that certain isolates of a given collection
might be directly related, the identification of GI-6 in
clinical as well as environmental isolates from differ-
ent geographical origin suggests that GI-6 confers (or
had conferred at some stage) a selective advantage to
its carrier.
Discussion
Comparing the accessory genome of the P. aeruginosa
strains C3719, LESB58, PAO1, PA7, PA14, PA2192,
PACS2 revealed a total of 89 RGP’s, in which
different inserts of foreign DNA are found (Klock-
gether et al. 2011). These DNA inserts, which
apparently have been acquired by horizontal gene
transfer, contribute to the ongoing evolution of the P.
aeruginosa genome by conferring specific phenotypes
that are advantageous under certain selective condi-
tions. In this work we have focused on PA14GI-6, one
of the inserts found at RGP5 of strain PA14. As
illustrated in Fig. 1, this insert harbors a gene cluster
which ressembles those for the biosynthesis of the
enantiomeric siderophores Pch and EPch. While EPch
has so far been found in certain strains of P. protegens
only (Youard et al. 2011), Pch seems more widely
distributed and has been isolated from several pseu-
domonads (P. aeruginosa, P. fluorescens, P. akbaa-
lia), from members of the Burkholderia cepacia
complex, and recently also from the plant pathogen
Streptomyces scabies (Cox et al. 1981; Cuppels et al.
1987; Terano et al. 2002; Thomas 2007; Phoebe et al.
2001; Seipke et al. 2011). We thus hypothesized that
an ancester of the genomic island PA14GI-6 may have
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been involved at some stage in the dissemination of
Pch/EPch biosynthetic genes between these different
bacterial species and genera and wondered what
compound this island would specify todate. A detailed
bioinformatics analysis of its Pch/EPch-related gene
cluster (PA14_54940 to PA14_54870) predicted a
compound consisting of salicylate linked to two
cysteine-derived thiazoline rings which may have
the same stereochemical configuration as those of
EPch (Table 2). Having a large set of mutations in
potential homologs of these genes at hand, we were
able to test and confirm the predicted functions of
PA14_54940 as a bifunctional salicylate synthase/
salicyl-AMP ligase (for generation and activation of
salicylate; Fig. 2), of PA14_54930 as a Dha synthetase
(for coupling salicylate with a cysteine-derived thiaz-
oline ring; Fig. 2), of PA14_54910 as a type II
thioesterase (for quality control; Reimmann et al.
2004), and of PA14_54880 as a serine O-acetyltrans-
ferase (for increased cysteine biosynthesis; Kredich
1996).
Expression of the entire gene cluster and structural
analysis of the specified metabolite revealed its
identity with (R)-Dha (Fig. 4), an iron chelator with
antibacterial, antifungal and antitumor activity (Carmi
et al. 1994; Elliot et al. 1988). Despite these interesting
properties, the identification of Dha came as a surprise,
as the gene cluster clearly codes for a PchF homolog
(PA14_54920), and for two potential tailoring proteins
(PA14_54900 and PA14_54890). Obviously, biosyn-
thesis of a larger metabolite containing two thiazoline
rings is terminated prematurely, and a biosynthetic
intermediate is released from the thiotemplate
PA14_54930 giving rise to Dha. Indeed, Dha was
described as a byproduct of Pch biosynthesis in P.
aeruginosa, namely when the PchE-bound intermedi-
ate hydroxyphenyl-thiazoline is released by slow
hydrolysis of the thioester bond (Serino et al. 1997;
Patel et al. 2003; Quadri et al. 1999).
Why then would biosynthesis not proceed to the
end? Given that Dha contains only a single thiazoline
ring it is likely that during evolution, one or several
mutations in PA14_54920 have rendered this PchF
homolog non-functional. Analysis of the characteristic
sequence motifs in the predicted adenylation-thiola-
tion-condensation/cylization domains, and compari-
son with the motifs of PchF from P. aeruginosa and P.
protegens, revealed a very good motif conservation
except for an alternative key residue in the
PA14_54920 thiolation domain (GGTSL instead of
GGDSL). However, replacing the threonine codon
against an aspartate codon did not alter metabolite
production (data not shown), suggesting that addi-
tional mutations in PA14_54920 may prevent biosyn-
thesis to proceed.
In conclusion, we have shown here that PA14GI-6
does not (or no longer) code for a Pch/EPch-related
siderophore but has evolved to confer the ability of
Dha production to its host. The maintenance of GI-6 in
a large number of clinical and environmental P.
aeruginosa isolates (Fig. 5) indicates either that Dha
production could confer a selective advantage under
certain conditions or that the presence of this rather
small GI does not have a fitness cost.
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